Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | carbon monoxyde dehydrogenase small chain CoxS | 0.0044 | 0.0422 | 0.0568 |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase large chain CoxL | 0.0108 | 0.1629 | 0.618 |
Echinococcus granulosus | Hepatocellular carcinoma associated antigen 59 | 0.0241 | 0.4144 | 0.414 |
Mycobacterium ulcerans | carbon monoxide dehydrogenase | 0.0151 | 0.245 | 1 |
Mycobacterium ulcerans | aerobic-type carbon monoxide dehydrogenase subunit CoxL_2 | 0.0108 | 0.1629 | 0.618 |
Treponema pallidum | hypothetical protein | 0.0037 | 0.03 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0241 | 0.4144 | 1 |
Loa Loa (eye worm) | acetyltransferase | 0.0082 | 0.1138 | 0.2745 |
Trichomonas vaginalis | aldehyde oxidase, putative | 0.0228 | 0.3902 | 1 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0079 | 0.1094 | 0.1088 |
Onchocerca volvulus | 0.0241 | 0.4144 | 1 | |
Mycobacterium tuberculosis | Probable carbon monoxyde dehydrogenase (large chain) | 0.0108 | 0.1629 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0007 | 0.0018 |
Mycobacterium tuberculosis | Probable carbon monoxyde dehydrogenase (medium chain) | 0.0077 | 0.1053 | 0.5229 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.0022 | 0.0015 | 0.5 |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase large chain CoxL | 0.0068 | 0.0876 | 0.2678 |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase small chain CoxS | 0.0044 | 0.0422 | 0.0568 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0552 | 1 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0022 | 0.0007 | 0.0018 |
Brugia malayi | Hepatocellular carcinoma-associated antigen 59 family protein | 0.0241 | 0.4144 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0241 | 0.4144 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0241 | 0.4144 | 1 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0552 | 1 | 1 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0082 | 0.1138 | 0.1131 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0022 | 0.0015 | 0.5 |
Onchocerca volvulus | 0.0241 | 0.4144 | 1 | |
Trichomonas vaginalis | xanthine dehydrogenase, putative | 0.0228 | 0.3902 | 1 |
Echinococcus multilocularis | Hepatocellular carcinoma associated antigen 59 | 0.0241 | 0.4144 | 0.414 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0024 | 0.0053 | 0.0045 |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase medium chain CoxM | 0.0077 | 0.1053 | 0.3502 |
Loa Loa (eye worm) | hypothetical protein | 0.0241 | 0.4144 | 1 |
Mycobacterium ulcerans | aerobic-type carbon monoxide dehydrogenase subunit CoxM_2 | 0.0077 | 0.1053 | 0.3502 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0082 | 0.1138 | 0.1131 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0022 | 0.0007 | 0.0018 |
Trichomonas vaginalis | xanthine dehydrogenase, putative | 0.0228 | 0.3902 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0241 | 0.4144 | 0.414 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0082 | 0.1138 | 0.2732 |
Treponema pallidum | quinoline 2-oxidoreductase | 0.0036 | 0.0284 | 0.8682 |
Plasmodium falciparum | conserved protein, unknown function | 0.0241 | 0.4144 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (ADMET) | = 0 % | Phytotoxicity against directly seeded Oryza sativa (rice) seedlings assessed as phytotoxic activity ratings (0- no effect to 5-complete killing rating scale) at 100 g/a measured after 3 weeks post compound treatment under green house conditions | ChEMBL. | 27393589 |
Activity (functional) | = 74 % | Relieving activity against bensulfuron-methyl induced injury to Oryza sativa (rice) assessed as growth rate at 1 uM (Rbv = 46 to 53%) | ChEMBL. | 27393060 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.